Fusion Antibodies Fundamentals
| Sector: |
Healthcare |
| Market Cap (M): |
13.7673 |
| PE Ratio: |
|
| Dividend P/S: |
|
| Profit Margin: |
-0.9192 |
| Return (Assets): |
-0.5509 |
| Industry: |
Biotechnology |
| Volume: |
77,397 |
| PEG Ratio: |
|
| Dividend Yield: |
|
| Opr. Margin: |
-0.6444 |
| Return (Equity): |
-1.6437 |
| Trailing PE: |
|
| 52 Wk High: |
21 |
| 50 Day MA: |
12.575 |
| Ex Div Date: |
|
| Rev Per Share: |
0.015 |
| Forward PE: |
0 |
| 52 Wk Low: |
6.255 |
| 200 Day MA: |
13.522 |
| EPS Estimate: |
-0.007 |
| Rev Growth: |
-0.306 |
Share prices are end of day only and updates after midnight GMT. Data is gathered from historic databases such as Quandl and other reliable sources, however errors do occur. Please use for information purposes only.
FAB share price
